Mitral Annular Disjunction in Heritable Thoracic Aortic Disease: Insights From the Montalcino Aortic Consortium

Background Mitral annular disjunction (MAD), posterior displacement of the mitral valve leaflet hinge point, predisposes to arrhythmias or sudden cardiac death. We evaluated the burden of MAD, mitral valve prolapse (MVP), and mitral regurgitation (MR) by heritable thoracic aortic disease gene in a c...

Full description

Saved in:
Bibliographic Details
Main Authors: Kishan L. Asokan, Jennifer R. Landes, Wannes Renders, Laura Muiño Mosquera, Julie De Backer, David W. Jantzen, Anji T. Yetman, Gisela Teixido‐Tura, Arturo Evangelista, Richmond Jeremy, Edward G. Jones, Shaine Morris, Tam Doan, Maral Ouzonian, Alan Braverman, Guillaume Jondeau, Olivier Milleron, Dianna M. Milewicz, Siddharth K. Prakash
Format: Article
Language:English
Published: Wiley 2024-11-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.036274
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850065589067841536
author Kishan L. Asokan
Jennifer R. Landes
Wannes Renders
Laura Muiño Mosquera
Julie De Backer
David W. Jantzen
Anji T. Yetman
Gisela Teixido‐Tura
Arturo Evangelista
Richmond Jeremy
Edward G. Jones
Shaine Morris
Tam Doan
Maral Ouzonian
Alan Braverman
Guillaume Jondeau
Olivier Milleron
Dianna M. Milewicz
Siddharth K. Prakash
author_facet Kishan L. Asokan
Jennifer R. Landes
Wannes Renders
Laura Muiño Mosquera
Julie De Backer
David W. Jantzen
Anji T. Yetman
Gisela Teixido‐Tura
Arturo Evangelista
Richmond Jeremy
Edward G. Jones
Shaine Morris
Tam Doan
Maral Ouzonian
Alan Braverman
Guillaume Jondeau
Olivier Milleron
Dianna M. Milewicz
Siddharth K. Prakash
author_sort Kishan L. Asokan
collection DOAJ
description Background Mitral annular disjunction (MAD), posterior displacement of the mitral valve leaflet hinge point, predisposes to arrhythmias or sudden cardiac death. We evaluated the burden of MAD, mitral valve prolapse (MVP), and mitral regurgitation (MR) by heritable thoracic aortic disease gene in a cross‐sectional analysis of 2014–2023 data in the Montalcino Aortic Consortium registry. Methods and Results MAD was determined by direct measurement of echocardiographic images. MR and MVP were defined according to current clinical guidelines. Associations were evaluated using χ2 or Fisher exact tests. MR and MVP were enriched in Montalcino Aortic Consortium participants (672) with pathogenic variants (PV) in transforming growth factor‐β pathway genes. The combination of MR and MVP was associated with mitral surgery and arrhythmias. In the subgroup with available images, MAD was enriched in SMAD3 PV compared with other transforming growth factor‐β PV (prevalence ratio 1.8 [1.1–2.8], P <0.02). Severe disjunction (>10 mm) was only observed in the transforming growth factor‐β subgroup and was further enriched in participants with SMAD3 PV (prevalence ratio 3.1 [1.1–8.6]). MVP (prevalence ratio 5.2 [3.0–9.0]) and MR (PR 2.7 [1.8–3.9]) were increased in participants with MAD, but MAD was not independently associated with adverse cardiac or aortic events. Conclusions Pathological mitral valve phenotypes are more prevalent in individuals with PV in transforming growth factor‐β pathway genes, particularly SMAD3. MR and MVP but not MAD are associated with adverse aortic and cardiac events. Because congenital mitral disease may be the primary presenting feature of SMAD3 PV, genetic testing for heritable thoracic aortic disease should be considered for such individuals, especially if they also have a family history of heritable thoracic aortic disease.
format Article
id doaj-art-6412c93cdefe495f925a1a5d4ad6db2b
institution DOAJ
issn 2047-9980
language English
publishDate 2024-11-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj-art-6412c93cdefe495f925a1a5d4ad6db2b2025-08-20T02:48:57ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802024-11-01132110.1161/JAHA.124.036274Mitral Annular Disjunction in Heritable Thoracic Aortic Disease: Insights From the Montalcino Aortic ConsortiumKishan L. Asokan0Jennifer R. Landes1Wannes Renders2Laura Muiño Mosquera3Julie De Backer4David W. Jantzen5Anji T. Yetman6Gisela Teixido‐Tura7Arturo Evangelista8Richmond Jeremy9Edward G. Jones10Shaine Morris11Tam Doan12Maral Ouzonian13Alan Braverman14Guillaume Jondeau15Olivier Milleron16Dianna M. Milewicz17Siddharth K. Prakash18University of Texas Health Science Center at Houston TXUniversity of Texas Health Science Center at Houston TXGhent University Hospital Ghent BelgiumGhent University Hospital Ghent BelgiumGhent University Hospital Ghent BelgiumUniversity of Nebraska Medical Center Omaha NEUniversity of Nebraska Medical Center Omaha NEUniversity Hospital Vall d’Hebron Barcelona SpainUniversity Hospital Vall d’Hebron Barcelona SpainUniversity of Sydney AustraliaTexas Children’s Hospital Houston TXTexas Children’s Hospital Houston TXTexas Children’s Hospital Houston TXUniversity of Toronto CanadaWashington University School of Medicine St Louis MOHospital Bichat‐Claude Bernard Paris FranceHospital Bichat‐Claude Bernard Paris FranceUniversity of Texas Health Science Center at Houston TXUniversity of Texas Health Science Center at Houston TXBackground Mitral annular disjunction (MAD), posterior displacement of the mitral valve leaflet hinge point, predisposes to arrhythmias or sudden cardiac death. We evaluated the burden of MAD, mitral valve prolapse (MVP), and mitral regurgitation (MR) by heritable thoracic aortic disease gene in a cross‐sectional analysis of 2014–2023 data in the Montalcino Aortic Consortium registry. Methods and Results MAD was determined by direct measurement of echocardiographic images. MR and MVP were defined according to current clinical guidelines. Associations were evaluated using χ2 or Fisher exact tests. MR and MVP were enriched in Montalcino Aortic Consortium participants (672) with pathogenic variants (PV) in transforming growth factor‐β pathway genes. The combination of MR and MVP was associated with mitral surgery and arrhythmias. In the subgroup with available images, MAD was enriched in SMAD3 PV compared with other transforming growth factor‐β PV (prevalence ratio 1.8 [1.1–2.8], P <0.02). Severe disjunction (>10 mm) was only observed in the transforming growth factor‐β subgroup and was further enriched in participants with SMAD3 PV (prevalence ratio 3.1 [1.1–8.6]). MVP (prevalence ratio 5.2 [3.0–9.0]) and MR (PR 2.7 [1.8–3.9]) were increased in participants with MAD, but MAD was not independently associated with adverse cardiac or aortic events. Conclusions Pathological mitral valve phenotypes are more prevalent in individuals with PV in transforming growth factor‐β pathway genes, particularly SMAD3. MR and MVP but not MAD are associated with adverse aortic and cardiac events. Because congenital mitral disease may be the primary presenting feature of SMAD3 PV, genetic testing for heritable thoracic aortic disease should be considered for such individuals, especially if they also have a family history of heritable thoracic aortic disease.https://www.ahajournals.org/doi/10.1161/JAHA.124.036274cardiovascular geneticscongenital heart diseaseLoeys–Dietz syndromemitral valvethoracic aortic aneurysms and dissections
spellingShingle Kishan L. Asokan
Jennifer R. Landes
Wannes Renders
Laura Muiño Mosquera
Julie De Backer
David W. Jantzen
Anji T. Yetman
Gisela Teixido‐Tura
Arturo Evangelista
Richmond Jeremy
Edward G. Jones
Shaine Morris
Tam Doan
Maral Ouzonian
Alan Braverman
Guillaume Jondeau
Olivier Milleron
Dianna M. Milewicz
Siddharth K. Prakash
Mitral Annular Disjunction in Heritable Thoracic Aortic Disease: Insights From the Montalcino Aortic Consortium
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
cardiovascular genetics
congenital heart disease
Loeys–Dietz syndrome
mitral valve
thoracic aortic aneurysms and dissections
title Mitral Annular Disjunction in Heritable Thoracic Aortic Disease: Insights From the Montalcino Aortic Consortium
title_full Mitral Annular Disjunction in Heritable Thoracic Aortic Disease: Insights From the Montalcino Aortic Consortium
title_fullStr Mitral Annular Disjunction in Heritable Thoracic Aortic Disease: Insights From the Montalcino Aortic Consortium
title_full_unstemmed Mitral Annular Disjunction in Heritable Thoracic Aortic Disease: Insights From the Montalcino Aortic Consortium
title_short Mitral Annular Disjunction in Heritable Thoracic Aortic Disease: Insights From the Montalcino Aortic Consortium
title_sort mitral annular disjunction in heritable thoracic aortic disease insights from the montalcino aortic consortium
topic cardiovascular genetics
congenital heart disease
Loeys–Dietz syndrome
mitral valve
thoracic aortic aneurysms and dissections
url https://www.ahajournals.org/doi/10.1161/JAHA.124.036274
work_keys_str_mv AT kishanlasokan mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium
AT jenniferrlandes mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium
AT wannesrenders mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium
AT lauramuinomosquera mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium
AT juliedebacker mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium
AT davidwjantzen mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium
AT anjityetman mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium
AT giselateixidotura mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium
AT arturoevangelista mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium
AT richmondjeremy mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium
AT edwardgjones mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium
AT shainemorris mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium
AT tamdoan mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium
AT maralouzonian mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium
AT alanbraverman mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium
AT guillaumejondeau mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium
AT oliviermilleron mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium
AT diannammilewicz mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium
AT siddharthkprakash mitralannulardisjunctioninheritablethoracicaorticdiseaseinsightsfromthemontalcinoaorticconsortium